Last updated on October 2017

Prismaflex HF20 Set and Prismaflex System 7.10 for Acute CRRT in Children

Brief description of study

The primary objective of this study is to evaluate the efficacy of the Gambro Prismaflex® HF20 Set based on testing the hypothesis that it delivers sufficient renal replacement therapy to effectively treat acute kidney injury (AKI) in pediatric patients by reducing blood urea nitrogen (BUN).

Clinical Study Identifier: NCT02561247

Contact Investigators or Research Sites near you

Start Over

Scott Sutherland, MD

Stanford University Medical Center - Department of Pediatrics
Stanford, CA United States
  Connect »

Patrick Brophy, MD

University of Iowa - Department of Pediatrics, Division of Nephrology Dialysis & Transplantation
Iowa City, IA United States
  Connect »

Rick Hackbarth, MD

Helen DeVos Children's Hospital
Grand Rapids, MI United States
  Connect »

Stuart L Goldstein, MD

University of Cincinnati College of Medicine - Division of Nephrology and Hypertention & The Heart Institute
Cincinnati, OH United States
  Connect »

Raymond Quigley, MD

Children's Medical Center of Dallas
Dallas, TX United States
  Connect »

Raj Munshi, MD

Seattle Children's Hospital - Divison of Nephrology
Seattle, WA United States
  Connect »